| Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells W Pierson, B Cauwe, A Policheni, SM Schlenner, D Franckaert, J Berges, ... Nature immunology 14 (9), 959-965, 2013 | 250 | 2013 |
| Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis S Humblet-Baron, B Sather, S Anover, S Becker-Herman, DJ Kasprowicz, ... The Journal of clinical investigation 117 (2), 407-418, 2007 | 211 | 2007 |
| Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity L Vanderbeke, P Van Mol, Y Van Herck, F De Smet, S Humblet-Baron, ... Nature communications 12 (1), 4117, 2021 | 203 | 2021 |
| Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency L Van Eyck, L De Somer, D Pombal, S Bornschein, G Frans, ... Arthritis & rheumatology 67 (6), 1592-1597, 2015 | 116 | 2015 |
| Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis A Meyer-Bahlburg, S Becker-Herman, S Humblet-Baron, S Khim, ... Blood, The Journal of the American Society of Hematology 112 (10), 4158-4169, 2008 | 111 | 2008 |
| Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer PW Yu, RS Tabuchi, RM Kato, A Astrakhan, S Humblet-Baron, K Kipp, ... Blood 104 (5), 1281-1290, 2004 | 109 | 2004 |
| Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age E Castermans, M Hannon, J Dutrieux, S Humblet-Baron, L Seidel, ... haematologica 96 (2), 298, 2011 | 92 | 2011 |
| Human immune diversity: from evolution to modernity A Liston, S Humblet-Baron, D Duffy, A Goris Nature immunology 22 (12), 1479-1489, 2021 | 84 | 2021 |
| B cell–specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia HM Kerns, BY Ryu, BV Stirling, BD Sather, A Astrakhan, S Humblet-Baron, ... Blood, The Journal of the American Society of Hematology 115 (11), 2146-2155, 2010 | 79 | 2010 |
| Infusion of clinical‐grade enriched regulatory T cells delays experimental xenogeneic graft‐versus‐host disease M Hannon, C Lechanteur, S Lucas, J Somja, L Seidel, L Belle, F Bruck, ... Transfusion 54 (2), 353-363, 2014 | 76 | 2014 |
| Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice G Ehx, J Somja, HJ Warnatz, C Ritacco, M Hannon, L Delens, G Fransolet, ... Frontiers in immunology 9, 1943, 2018 | 72 | 2018 |
| Impact of pre-transplant anti-T cell globulin (ATG) on immune recovery after myeloablative allogeneic peripheral blood stem cell transplantation S Servais, C Menten-Dedoyart, Y Beguin, L Seidel, A Gothot, C Daulne, ... PloS one 10 (6), e0130026, 2015 | 65 | 2015 |
| Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome A Astrakhan, BD Sather, BY Ryu, S Khim, S Singh, S Humblet-Baron, ... Blood, The Journal of the American Society of Hematology 119 (19), 4395-4407, 2012 | 64 | 2012 |
| Case report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome F Staels, A Betrains, FJSH Woei-A-Jin, N Boeckx, M Beckers, A Bervoets, ... Frontiers in immunology 12, 678927, 2021 | 62 | 2021 |
| Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19 J Neumann, T Prezzemolo, L Vanderbeke, CP Roca, M Gerbaux, ... Clinical & translational immunology 9 (11), e1204, 2020 | 62 | 2020 |
| IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis S Humblet-Baron, D Franckaert, J Dooley, S Bornschein, B Cauwe, ... Journal of Allergy and Clinical Immunology 138 (1), 200-209. e8, 2016 | 60 | 2016 |
| Olmsted syndrome: exploration of the immunological phenotype D Danso-Abeam, J Zhang, J Dooley, KA Staats, L Van Eyck, ... Orphanet journal of rare diseases 8, 1-8, 2013 | 58 | 2013 |
| IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis S Humblet-Baron, D Franckaert, J Dooley, F Ailal, A Bousfiha, C Deswarte, ... Journal of Allergy and Clinical Immunology 143 (6), 2215-2226. e7, 2019 | 57 | 2019 |
| Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells I Smets, B Fiddes, JE Garcia-Perez, D He, K Mallants, W Liao, J Dooley, ... Brain 141 (3), 786-796, 2018 | 57 | 2018 |
| Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disorders BD Sather, BY Ryu, BV Stirling, M Garibov, HM Kerns, S Humblet-Baron, ... Molecular Therapy 19 (3), 515-525, 2011 | 57 | 2011 |
